Sotac Pharmaceuticals

Sotac Pharmaceuticals Revenue per Share

The Revenue per Share of Sotac Pharmaceuticals (SOTAC.NS) as of Oct 19, 2026 is 87.77 INR. In the previous year, Revenue per Share was 93.96 INR — a change of -6.59% (lower).

Revenue per Share

87.77INR

YoY

-6.59%

Last updated:

Revenue per Share of Sotac Pharmaceuticals is 2025 87.77 INR. Revenue per Share of Sotac Pharmaceuticals was 2024 93.96 INR. It decreases by -6.59% lower compared to the previous year.

The Sotac Pharmaceuticals Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2020
25.89 INR
Jan 1, 2021
44.20 INR
Jan 1, 2022
66.20 INR
Jan 1, 2023
52.47 INR
Jan 1, 2024
93.96 INR
Jan 1, 2025
87.77 INR
The Sotac Pharmaceuticals Revenue per Share history
YEARRevenue per ShareYoY
87.77INR-6.59%
93.96INR+79.07%
52.47INR-20.74%
66.20INR+49.77%
44.20INR+70.76%
25.89INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sotac Pharmaceuticals Stock analysis

What does Sotac Pharmaceuticals do? Sotac Pharmaceuticals Ltd., headquartered in Ahmedabad, Gujarat, operates in the Health Care sector, specializing in pharmaceutical manufacturing. The company develops and manufactures products such as Non Beta-Lactam tablets, capsules, syrups, and external preparations on a contract basis for various marketers. Its therapeutic portfolio covers Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Anti-Cold, Anti-Allergic, Derma Products, and a wide range of antibiotics including Non-IP-Lactams and Cephalosporin. Listed on 13 April 2023, Sotac employs 89 people and has subsidiaries including SOTAC Healthcare, SOTAC Research, and SOTAC Lifescience. Sotac Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sotac Pharmaceuticals stock

Revenue per Share of Sotac Pharmaceuticals is 87.77 INR in 2025.

Revenue per Share of Sotac Pharmaceuticals changed from 93.96 INR to 87.77 INR, representing a -6.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share Sotac Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Sotac Pharmaceuticals

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Sotac Pharmaceuticals